DUBAI, UAE. 10th November 2016: SNS Research's latest report indicates that global mHealth (Mobile Healthcare) revenue is expected to surpass $23 Billion by the end of 2017.
As healthcare service providers seek to maximize their patient outreach while minimizing costs, many view mobile healthcare (or mHealth) as the solution to improve healthcare cost–efficiency. mHealth refers to the usage of mobile communications technology and devices to enhance access to healthcare information, improve distribution of routine and emergency health services, and provide diagnostic services.
Mobile operators also view mHealth as a lucrative opportunity for the monetization of their mobile connectivity services as a growing proportion of their subscribers adopt healthcare centric wearables. Given that most operators have established themselves as reputable consumer brands, they are also eyeing at opportunities to offer services beyond simple connectivity. Many operators already offer branded or co-branded end-to-end mHealth solutions to their customer bases.
In addition, mHealth offers a multitude to opportunities to the pharmaceutical industry ranging from enhanced R&D activities and medication adherence to securing the supply chain and combating counterfeit drugs.
Driven by the thriving ecosystem, SNS Research estimates that the mHealth market will account for over $23 Billion in 2017 alone. Despite barriers relating to regulation, patient acceptance and privacy concerns, SNS Research estimates further growth at a CAGR of more than 35% over the next three years.
The “mHealth (Mobile Healthcare) Ecosystem: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts“ report presents an in–depth assessment of the global mHealth market. In addition to covering key market drivers, challenges, future roadmap, value chain analysis, deployment case studies, service/product strategies and strategic recommendations, the report also presents comprehensive forecasts for the mHealth market from 2017 till 2030. The forecasts and historical revenue figures are individually segmented for 5 individual submarkets, 29 use case categories, 5 ecosystem player categories, 6 geographical regions and 34 countries.
The report will be of value to current and future potential investors into the mHealth sector, as well as enabling technology providers, mHealth device OEMs, mobile operators, healthcare providers, pharmaceutical companies, healthcare insurers, government healthcare institutions, application developers and software/service vendors who wish to broaden their knowledge of the mHealth ecosystem.
For further information concerning the SNS Research report "The mHealth (Mobile Healthcare) Ecosystem: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts" please visit: http://www.snstelecom.com/mhealth
For a sample please contact:
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com
About SNS Research
SNS Research is one of the most foremost market intelligence and consulting firms for the worldwide telecommunications industry, with a particular focus on wireless infrastructure and mobile devices. Developed by leading industry analysts our market intelligence and consultancy services provide unique insights to the global telecommunications industry with information ranging from niche details of mobile handset models to tracking to large network infrastructure contracts and cellular network operator metrics. Whether your focus is strategic decision making, service development, investment or marketing, our services will allow you to make optimal decisions with self-assurance.